The health benefits of dietary polyphenols on pediatric intestinal diseases: Mechanism of action, clinical evidence and future research progress
Phytotherapy Research · 2024
DOI: 10.1002/ptr.8218 ↗At a glance
Übersichtsarbeit in Phytotherapy Research, 2024. Written by Yu-Rou Jiang and 9 co-authors. Institution: State Key Laboratory of Southwestern Chinese Medicine Resources, Chengdu University of Traditional Chinese Medicine, Chengdu, China. Major MEDLINE topics: Polyphenols, Intestinal Diseases. Cited 5 times so far (Crossref); 109 references. Funded by: China Postdoctoral Science Foundation, National Natural Science Foundation of China, Study and Research Joint Laboratory Project of Chengdu University of TCM & Sanajon Pharmaceutical Group.
Abstract (original language)
Pediatric intestinal development is immature, vulnerable to external influences and produce a variety of intestinal diseases. At present, breakthroughs have been made in the treatment of pediatric intestinal diseases, but there are still many challenges, such as toxic side effects, drug resistance, and the lack of more effective treatments and specific drugs. In recent years, dietary polyphenols derived from plants have become a research hotspot in the treatment of pediatric intestinal diseases due to their outstanding pharmacological activities such, as anti‐inflammatory, antibacterial, antioxidant and regulation of intestinal flora. This article reviewed the mechanism of action and clinical evidence of dietary polyphenols in the treatment of pediatric intestinal diseases, and discussed the influence of physiological characteristics of children on the efficacy of polyphenols, and finally prospected the new dosage forms of polyphenols in pediatrics.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- State Key Laboratory of Southwestern Chinese Medicine Resources, Chengdu University of Traditional Chinese Medicine, Chengdu, China.
- Department of Pharmacy, Sichuan Nursing Vocational College, Chengdu, China.
- Sichuan Provincial Engineering Research Center of Innovative Re-development of Famous Classical Formulas, Tianfu TCM Innovation Harbour, Chengdu University of Traditional Chinese Medicine, Chengdu, China.
- Sanajon Pharmaceutical Group, Chengdu, China.
- State key Laboratory of Southwestern Chinese Medicine Resources, Innovative Institute of Chinese Medicine and Pharmacy, Meishan Hospital, Chengdu University of Traditional Chinese Medicine, Chengdu, China.
- TCM Regulating Metabolic Diseases Key Laboratory of Sichuan Province, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, PR China.
ORCID profiles: Yu-Rou Jiang, Ding-Kun Zhang
Funding
- China Postdoctoral Science Foundation
- National Natural Science Foundation of China
- Study and Research Joint Laboratory Project of Chengdu University of TCM & Sanajon Pharmaceutical Group
Cite
APA
Jiang, Y. R., Liu, R. J., Tang, J., Li, M. Q., Zhang, D. K., Pei, Z. Q., Fan, S. H., Xu, R. C., Huang, H. Z., & Lin, J. Z. (2024). The health benefits of dietary polyphenols on pediatric intestinal diseases: Mechanism of action, clinical evidence and future research progress. Phytotherapy Research. https://doi.org/10.1002/ptr.8218
Vancouver
Jiang YR, Liu RJ, Tang J, Li MQ, Zhang DK, Pei ZQ, et al. The health benefits of dietary polyphenols on pediatric intestinal diseases: Mechanism of action, clinical evidence and future research progress. Phytotherapy Research. 2024. doi:10.1002/ptr.8218
BibTeX
@article{Jiang2024,
author = {Jiang, Yu-Rou and Liu, Ren-Jie and Tang, Jun and Li, Meng-Qi and Zhang, Ding-Kun and Pei, Zhao-Qing and Fan, San-Hu and Xu, Run-Chun and Huang, Hao-Zhou and Lin, Jun-Zhi},
title = {The health benefits of dietary polyphenols on pediatric intestinal diseases: Mechanism of action, clinical evidence and future research progress},
journal = {Phytotherapy Research},
year = {2024},
doi = {10.1002/ptr.8218}
}
EUVIMED